Matches any text strings used to describe a molecule.
Systematic Name, Synonym, Trade Name, Registry Number, SMILES, InChI or CSID

Systematic names 1,2-dihydroxybenzene
Synonyms AIBN
Trade names Aspirin
Registry numbers 7732-18-5
SMILES O=C(OCC)C
InChl InChI=1/CH4/h1H4
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 69 results

Search term: C10H14N5O6P (Found by molecular formula)
1234
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
12079

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1
C10H14N5O6P331.221810719425401331
146416

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(6(2-16)20-7)21-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m0/s1
C10H14N5O6P331.2218323900
601

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)
C10H14N5O6P331.2218173900
9556869

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C10H14N5O6P/c11-10-13-8-7(9(16)14-10)12-4-15(8)6-2-1-5(21-6)3-20-22(17,18)19/h4-6H,1-3H2,(H2,17,18,19)(H3,11,13,14,16)/t5-,6+/m0/s1
C10H14N5O6P331.2218141200
8059671

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(16)1-5(21-10)2-20-22(17,18)19/h3-6,10,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,10+/m0/s1
C10H14N5O6P331.2218131500
21211602

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C10H14N5O6P/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(21-8)4-20-22(18)19/h3,6-8,22H,2,4H2,1H3,(H,18,19)(H,12,16,17)/t6-,7+,8+/m0/s1
C10H14N5O6P331.2218101600
9465453

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C10H14N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(21-10)1-22(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1
C10H14N5O6P331.22187500
415061

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(21-8)4-22(18,19)20/h3,6-8H,2,4H2,1H3,(H,12,16,17)(H2,18,19,20)/t6-,7+,8+/m0/s1
C10H14N5O6P331.22187600
3819715

0 of 2 defined stereocentres - 0/2 defined
InChI=1/C10H14N5O6P/c11-10-13-8-7(9(16)14-10)12-4-15(8)6-2-1-5(21-6)3-20-22(17,18)19/h4-6H,1-3H2,(H2,17,18,19)(H3,11,13,14,16)
C10H14N5O6P331.22185400
1423

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(6(2-16)20-7)21-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)
C10H14N5O6P331.22185700
4976353

Double-bond stereo

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C10H14N5O6P/c11-10-13-8-7(9(17)14-10)12-5-15(8)21-4-6(3-16)1-2-22(18,19)20/h1-2,5-6,16H,3-4H2,(H2,18,19,20)(H3,11,13,14,17)/b2-1+
C10H14N5O6P331.22185400
21230605

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6+,7+/m1/s1
C10H14N5O6P331.22185400
34999874

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-8-7-9(13-3-12-8)15(4-14-7)10-5(1-16)6(21-10)2-20-22(17,18)19/h3-6,10,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6-,10-/m1/s1
C10H14N5O6P331.22185500
19508659

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-9-8-10(13-3-12-9)15(4-14-8)7-1-5(16)6(21-7)2-20-22(17,18)19/h3-7,16H,1-2H2,(H2,11,12,13)(H2,17,18,19)/t5-,6-,7+/m1/s1
C10H14N5O6P331.22184400
21607533

0 of 4 defined stereocentres - 0/4 defined
InChI=1/C10H14N5O6P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(21-10)1-20-22(18)19/h2-4,6-7,10,16-17,22H,1H2,(H,18,19)(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
C10H14N5O6P331.221841400
8077721

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-10-13-8-7(9(17)14-10)12-3-15(8)2-5-4(16)1-6(21-5)22(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6-/m0/s1
C10H14N5O6P331.22184300
8307105

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-10-13-8-7(9(17)14-10)12-3-15(8)2-5-4(16)1-6(21-5)22(18,19)20/h3-6,16H,1-2H2,(H2,18,19,20)(H3,11,13,14,17)/t4-,5+,6+/m0/s1
C10H14N5O6P331.22184300
4440841

3 of 3 defined stereocentres - 3/3 defined
InChI=1/C10H14N5O6P/c11-8-6-9(13-2-12-8)15(3-14-6)10-7(16)5(1-20-10)21-4-22(17,18)19/h2-3,5,7,10,16H,1,4H2,(H2,11,12,13)(H2,17,18,19)/t5-,7+,10+/m0/s1
C10H14N5O6P331.2218213200
396077

4 of 4 defined stereocentres - 4/4 defined
InChI=1/C10H14N5O6P/c1-4-6(16)7(21-22(17,18)19)10(20-4)15-3-14-5-8(11)12-2-13-9(5)15/h2-4,6-7,10,16H,1H3,(H2,11,12,13)(H2,17,18,19)/t4-,6-,7-,10-/m1/s1
C10H14N5O6P331.22183400
10725739

0 of 3 defined stereocentres - 0/3 defined
InChI=1/C10H14N5O6P/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(21-8)4-22(18,19)20/h3,6-8H,2,4H2,1H3,(H,12,16,17)(H2,18,19,20)
C10H14N5O6P331.22183200
1234

Advertisement